Advertisement

The cost of sequencing a human genome is plummeting, and soon many people may obtain a copy of their own. But how useful is that information to patients, especially if their genes predict untreatable, fatal diseases? Hank Greely discusses the promise and the pitfalls of genetic testing.

Advertisement
Advertisement